The Brilliant II QPCR and QRT-PCR reagents provide improved performance on the Stratagene Mx systems. They offer improved performance with earlier threshold cycle (Ct) detection across a wide dynamic range.
Organelle and Cellular Lights reagents are recombinant baculoviruses that, on entry into mammalian cells, direct the expression of fluorescent proteins (cyan, green, yellow, orange and red) fused to peptide targeting sequences.
AMCELGROW Medium from ID Labs is optimised for the primary in vitro culture of human amniotic fluid cells and chorionic villi (CV) samples in open (5% CO2) systems. These primary cultures can then be used for such cytogenetic procedures as karyotyping and FISH.
To facilitate further development of new kinase inhibitors, BIOMOL offers over 120 active recombinant kinases and associated substrates for inhibitor screening or selectivity studies.
The monoclonal therapeutic and diagnostic antibodies market is expected to increase by 80% by 2012, according to a technical market research report by BCC Research.
NorthernLights (from R&D Systems) fluorescent secondary antibodies and streptavidin conjugates are bright and resistant to photobleaching.
Lipofectamine LTX Reagent offers a solution for gene expression as it is a plasmid DNA-specific transfection reagent that can provide the same level of reproducible and efficient gene expression in a wide range of cell lines, including primary and disease-related cells. Lipofectamine LTX Reagent is synthesised from 100% animal origin-free components, making it easy to validate the absence of zoonotic diseases, such as BSE or viruses, in experiments or cell lines. A certificate of origin may be obtained.
The new MesenPRO RS Medium is a reduced serum (2%) medium specifically formulated to support the growth of human mesenchymal stem cells (MSCs) in culture. MesenPRO RS Medium consistently improves MSC expansion compared with conventional serum-supplemented media. Using MesenPRO RS Medium, MSCs can be expanded for multiple passages while maintaining their multi-potential phenotype (ie, differentiation into osteogenic, chondrogenic and adipogenic lineages).
In order to investigate the status and extent of protein ubiquitinylation, it is necessary to have available a range of antibodies capable of differentiating firstly between free ubiquitin and ubiquitin-protein conjugates and, secondly, between those that are monoubiquitinylated and those that are polyubiquitinylated.